Franklin Templeton ETF Trust. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| GUARDANT HEALTH INCGH | 9.09% | $2.54M | 16,927 |
| NATERA INCNTRA | 7.46% | $2.08M | 7,679 |
| KRYSTAL BIOTECH INCKRYS | 6.33% | $1.77M | 4,757 |
| LIGAND PHARMACEUTICALS INCLGND | 4.62% | $1.29M | 4,085 |
| ADAPTIVE BIOTECHNOLOGIES CORPADPT | 3.99% | $1.11M | 51,956 |
| UNITED THERAPEUTICS CORPUTHR | 3.51% | $980.17K | 1,809 |
| BRIDGEBIO PHARMA INCBBIO | 3.50% | $977.85K | 13,129 |
| ELI LILLY & COMPANYLLY | 2.95% | $825.21K | 688 |
| TWIST BIOSCIENCE CORPTWST | 2.85% | $795.88K | 7,736 |
| VERTEX PHARMACEUTICALS INCVRTX | 2.75% | $767.45K | 1,545 |
| ASTRAZENECA PLC | 2.70% | $754.50K | 3,979 |
| TRAVERE THERAPEUTICS INCTVTX | 2.59% | $724.50K | 12,753 |
| INSMED INCINSM | 2.44% | $681.09K | 6,388 |
| CORTEVA INCCTVA | 2.25% | $629.67K | 7,435 |
| MEDPACE HOLDINGS INCMEDP | 2.15% | $600.03K | 1,133 |
| ALNYLAM PHARMACEUTICALS INCALNY | 1.96% | $546.67K | 1,816 |
| TEMPUS AI INCTEM | 1.95% | $544.37K | 9,397 |
| IONIS PHARMACEUTICALS INCIONS | 1.91% | $534.34K | 6,739 |
| ARGENX SE | 1.64% | $523.94K | 494 |
| NEUROCRINE BIOSCIENCES INCNBIX | 1.84% | $515.38K | 3,058 |
| REGENERON PHARMACEUTICALS INCREGN | 1.80% | $501.95K | 805 |
| VERACYTE INCVCYT | 1.64% | $459.21K | 7,819 |
| PTC THERAPEUTICS INCPTCT | 1.46% | $408.58K | 5,009 |
| BIONTECH SEBNTX | 1.38% | $386.72K | 4,156 |
| STOKE THERAPEUTICS INCSTOK | 1.33% | $371.34K | 11,349 |
| CHARLES RIVER LABORATORIES INTERNATIONAL INCCRL | 1.26% | $352.89K | 1,556 |
| GRAIL INCGRAL | 1.09% | $304.21K | 4,456 |
| ANAPTYSBIO INCANAB | 1.04% | $289.58K | 4,290 |
| CRISPR THERAPEUTICS AG | 0.98% | $274.34K | 5,030 |
| REPLIGEN CORPRGEN | 0.98% | $274.11K | 2,009 |
| CADENCE DESIGN SYSTEMS INCCDNS | 0.97% | $272.11K | 725 |
| SARTORIUS AGPreferred | 0.85% | $271.61K | 905 |
| BEAM THERAPEUTICS INCBEAM | 0.93% | $260.04K | 7,577 |
| PRAXIS PRECISION MEDICINES INCPRAX | 0.86% | $240.38K | 718 |
| AXSOME THERAPEUTICS INCAXSM | 0.82% | $229.10K | 936 |
| CAREDX INCCDNA | 0.82% | $228.00K | 8,000 |
| JAZZ PHARMACEUTICALS PLC | 0.78% | $218.08K | 905 |
| CATALYST PHARMACEUTICALS INC | 0.77% | $215.77K | 6,865 |
| THERMO FISHER SCIENTIFIC INCTMO | 0.76% | $211.07K | 421 |
| IQVIA HOLDINGS INCIQV | 0.75% | $209.06K | 1,082 |
| HINGE HEALTH INCHNGE | 0.70% | $194.97K | 2,349 |
| ULTRAGENYX PHARMACEUTICAL INCRARE | 0.61% | $171.32K | 5,131 |
| AGILENT TECHNOLOGIES INCA | 0.58% | $162.45K | 1,223 |
| DANAHER CORPDHR | 0.57% | $160.38K | 842 |
| QIAGEN NV | 0.48% | $133.68K | 3,419 |
| RHYTHM PHARMACEUTICALS INCRYTM | 0.42% | $116.36K | 1,048 |
| ARCUTIS BIOTHERAPEUTICS INCARQT | 0.42% | $115.94K | 4,422 |
| KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 0.34% | $94.58K | 1,479 |
| TARSUS PHARMACEUTICALS INCTARS | 0.26% | $71.50K | 1,136 |
| BIO-RAD LABORATORIES INCBIO | 0.26% | $71.35K | 243 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.